WADA 2026 Report: Testing Growth Slows to 3.2%, Adverse Findings Flat at 0.78%

Last weekend I rebuilt WADA's testing series from its newly released annual report. The first thing I did, out of a habit that hardened in 2026, was line the years up side by side rather than trust the headline total. In 2026 the global system recorded 288,865 samples. In 2026 the figure was 297,965 — an increase of roughly 9,100 tests. An organisation announcing an increase in sample testing should be pleased with that.

Then I computed the rate. From 2026 to 2026, testing volume rose 12.5 percent. From 2026 to 2026, growth fell to 3.2 percent. Same curve, same unit, a near fourfold slowdown in a single year. Nothing in the report announces this deceleration — it sits quietly in two lines that a skimming reader will miss. That is the kind of data deviation I learned to see from my first GPS error: a small offset is enough to teach me that verification is everything.

What this report is, and why a swimming follower should read it

I need to be precise about the document before analysing anything. This is the World Anti-Doping Agency's global governance report, released under a 2026 label while aggregating testing activity from prior years — a publication-lag convention. I read it as a system snapshot, not a results bulletin.

It packages four data clusters. First, in-competition and out-of-competition testing volume, with a continuous series running from 2026 to 2026. Second, the adverse analytical finding rate, or AAF. Third, the compliance progress of national anti-doping organisations, measured through audits. Fourth, WADA's own finances. No athlete is named and no swimming technique is discussed. Every inference here therefore belongs to the system-governance layer, not the movement-technique layer.

But for someone working with swimming data, this report matters for an indirect yet weighty reason. Swimming is test-intensive: one athlete competes across multiple events, across a full year, both in and out of competition. A system's testing capacity is not neutral background — it is the material condition that makes a clean competition possible. When WADA slows down, that lag travels to every pool, starting with under-resourced federations.

Three years, three numbers, one unanswered question

The core data fit in a single frame. The AAF rate across the three most recent years runs as follows: 0.77 percent in 2026, 0.80 percent in 2026, and 0.78 percent in 2026. The swing sits within a band of plus or minus 0.03 percentage points. Statistically, this is a line flat enough to treat as a stable baseline rather than random noise.

This forces me to separate two variables usually collapsed into one. Testing volume is rising — slowly. The detection rate is flat. If the system were catching more, we would expect the detection rate to move with it. It does not move. There are two explanations, and I present both because the data does not yet give me the right to choose one.

The first: the true prevalence of doping in the athlete population is stable, and a flat number reflects a flat reality. The second: expanded testing is reaching a population with a positivity level comparable to the earlier one, so the aggregate rate holds even as coverage widens. The data table cannot distinguish between these. No model rescues me here, because both hypotheses fit the exact same series. Once more: I believe the number, but only after it clears three rounds of verification — and at this point, the third round is still open.

Meanwhile, the system's recovery sits in a different indicator. Average non-conformities in compliance audits fell from 25.5 to 20. That sounds like clear improvement. But it is drawn from exactly nine audits. Nine. With a sample that small, the confidence interval is wide enough that I cannot treat "20 versus 25.5" as a firm advance — it may be sampling noise and nothing more. I once built a recovery-index model on GPS data from 365 V.League players across three seasons, and the sample-size lesson I took from it still holds: an improvement on a small sample is a hypothesis, not a conclusion.

The blind spot the headline hides

Here the data contradicts the report's own title. While the average non-conformity count fell, one specific category rose: testing-process non-conformities account for 45 percent of all findings, up 11 percent year on year, with 23 percent of them rated critical. In other words, what improved is the aggregate picture; what worsened is the pivotal link — sample collection itself.

For anyone inside the trade, this is a familiar paradox. A system can look better on an average indicator while its weakness migrates to precisely the place no one measures. I met the same thing with my own GPS data in 2026, when the synchronisation software's summary looked fine but a full re-check of 14,000 samples over three months exposed three further systematic errors. The headline total never tells the whole story; it merely holds a place for whoever knows how to dig.

I read that 45 percent cautiously: the testing-process violations most likely concentrate in low-resource countries, where collection teams are thin and equipment is old. That is an inference, and I label it as one — low confidence, because the report does not break the figure down by country. If true, however, it touches swimming directly: developing swimming federations often sit in the low-resource group, and that is exactly the group most likely to fall short in out-of-competition testing.

Money: where the system loses force

No discussion of testing capacity can ignore funding. The report shows WADA fell 8.3 million US dollars short of its projected budget. Two large sums sit behind it: the United States has not paid 3.8 million US dollars, and Russia owes 3.9 million US dollars. This is where I lingered longest, because it explains another deviation I noted at the start — the slowdown in testing growth.

One accompanying detail makes the picture more complex than a simple pessimistic read: WADA still posted a net surplus of 1.2 million US dollars. But when an organisation both runs a surplus and misses its revenue target by a wide margin, that usually means aggressive cost-cutting or deferred spending. For a body whose primary output is testing capacity, deferred spending means compressing that very capacity. Surplus and shortfall can coexist — the cost is simply paid later, and the payer is usually the weakest federations.

In parallel, WADA is pushing another direction: investigation rather than blanket testing. More than 250 investigation operations, 88 laboratories dismantled, over 90 tons seized. I read this as a strategically positive signal — it shifts resources from broad routine testing to targeted action, and targeted action is always cheaper per result than broad routine work. This is the kind of resource reallocation any analytics unit, mine included, has to learn: when money thins out, intelligence becomes the substitute asset for volume.

The 2027 milestone and the compliance gap

The highest actionable value in the entire report is a short line: the 2027 World Anti-Doping Code was adopted in Busan, South Korea, and takes effect on January 1, 2027.

A fixed date like that is precious to any federation, because it turns compliance from "should do" into "must do before the deadline." But it also opens a risk window I want to name plainly: the period from now to early 2027 is a gap between the old rules and the new ones. In that gap, old-rule behaviour can persist, and slow-moving organisations will enter 2027 unprepared. For swimming — a sport with a dense, year-round calendar — compliance lag at national-federation level will reflect directly in sampling density at meets.

WADA also ran an athlete consultation round: more than 600 athletes and commissions from over 60 countries and more than 70 sports. This is a legitimate-building effort worth noting, and it shows athlete voice maturing as a force. But the report does not say whether that input actually changed the Code's substance or stopped at the listening stage. Between "we asked" and "we amended accordingly" lies a gap, and I have no data to bridge it.

The contrarian angle: more testing does not equal cleaner swimming

This is where I want to spend a few lines arguing against myself, because it runs counter to professional instinct.

The conventional telling puts an equals sign between "more testing" and "cleaner sport." The data does not permit that equals sign. Testing volume can rise while sample collection worsens — and this report shows exactly that, with testing-process violations up 11 percent. A test conducted off-protocol has low informational value, even zero, though it is still counted in the total. If so, no matter how handsome the 297,965 figure looks, it says nothing about the quality of fairness assurance.

I also have to guard against the temptation to read correlation as causation in the opposite direction. The slowdown in testing growth and the 8.3-million shortfall coincide in time but do not automatically prove that one caused the other. Two independent data clusters pointing the same way is a necessary condition for provisional belief, not sufficient proof. A pandemic season taught me to measure a league's health by its recovery index rather than its momentary points — and here, the anti-doping system's recovery index is flashing amber, not red.

Where I refuse to go further is into swimming technique. The report contains not one line on stroke, split, or performance. Any statement like "this trend will affect swimming events" is an exaggeration beyond what the data allows. I keep my rule: what the numbers cannot support, I do not say.

What to watch ahead

If I have to extract signals and set a watch schedule, I pick four.

First, the testing-volume growth rate in the next report. If it stalls or turns negative, that signals capacity erosion, not just a number. Second, the AAF rate — I will treat 0.85 percent as the threshold to note, because past that the story is no longer noise. Third, the share of testing-process violations: if it keeps exceeding 45 percent, that is a systemic problem in sample collection, not isolated error. Fourth, the contribution status of the United States and Russia — every change there shifts WADA's operational capacity directly, and that capacity flows down to every pool.

The 2027 Code is the anchor. From now to January 1, 2027, the question I keep is not "who is doping" but "does the system still have enough money and enough people to guarantee every lane is tested fairly." For a sport decided by hundredths of a second, fairness in testing also moves within that margin — and that margin, we are leaving empty. Data does not tell stories; it records everything so that I can tell them myself. But to tell it right, I need next year's report to answer one thing: is that flattening curve a sign of maturity, or of exhaustion.